000 01321 a2200361 4500
005 20250517214953.0
264 0 _c20191230
008 201912s 0 0 eng d
022 _a1473-4877
024 7 _a10.1080/03007995.2018.1476334
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDeleu, Dirk
245 0 0 _aOral disease-modifying therapies for multiple sclerosis in the Middle Eastern and North African (MENA) region: an overview.
_h[electronic resource]
260 _bCurrent medical research and opinion
_c02 2019
300 _a249-260 p.
_bdigital
500 _aPublication Type: Journal Article; Systematic Review
650 0 4 _aAfrica, Northern
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aMiddle East
650 0 4 _aMultiple Sclerosis, Relapsing-Remitting
_xdrug therapy
700 1 _aMesraoua, Boulenouar
700 1 _aCanibaƱo, Beatriz
700 1 _aMelikyan, Gayane
700 1 _aAl Hail, Hassan
700 1 _aEl-Sheikh, Lubna
700 1 _aAli, Musab
700 1 _aAl Hussein, Hassan
700 1 _aIbrahim, Faiza
700 1 _aHanssens, Yolande
773 0 _tCurrent medical research and opinion
_gvol. 35
_gno. 2
_gp. 249-260
856 4 0 _uhttps://doi.org/10.1080/03007995.2018.1476334
_zAvailable from publisher's website
999 _c28394045
_d28394045